FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/23/2024
Back to search
Official data from USPTO
RECEPTKINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RECEPTKINE
ST13
US500000079362319Class
5, 42
Filing
79362319
Registration
7376585
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
11/23/2024
Trademark type
Word
Nice classes
5, 42
Filing date
01/12/2023
Registration date
05/07/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/07/2024
Last transaction
05/07/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
MCMORROW, JANICE
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ILDONG PHARMACEUTICAL CO., LTD.
Representatives
Kwang Yup Chae Hauptman Ham, LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for immunity adjustment; Antibodies for veterinary purposes; Chemico-pharmaceutical preparations for use in the treatment of cancerimmune system related diseases and disorders; Albuminous preparations for medical purposes; Drugs for medical purposesfor use in the treatment of cancerimmune system related diseases and disorders; Colostral antibodies for medical purposes; Antibody reagents for medical purposes for use in the treatment of cancer; Blood for medical purposes; Enzymes for medical purposes; Pharmaceutical drugs for use in the treatment of cancerimmune system related diseases and disorders; Human immune globulin; Medicines for human purposesfor use in the treatment of cancerimmune system related diseases and disorders; Human plasma protein being blood plasma; Pharmaceutical preparations for use in the treatment of cancerimmune system related diseases and disorders; Haematogenblood substitutes for human use; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antivirals; Antigens for use in the treatment of cancer; Antibody reagents used for the detection of the antigens in cells and tissue for medical purposes; Pharmaceutical preparations for use in hematology
Class 42
Laboratory services relating to the production of monoclonal antibodies; Research and development of vaccines and medicines; Consultancy in the field of biotechnology; Research and development of technology for biotechnology; Scientific research in the field of biomedicine; Biological research; Biochemical research; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Drug discovery services; Development of pharmaceutical preparations and medicines; Testinginspection and research services in the fields of pharmaceuticalscosmetics and foodstuffs; Scientific research in the field of pharmacy; Scientific research in the field of genetic engineering; Medicine research; Laboratory research services relating to pharmaceuticals; Medical and pharmacological research services; Medical research; Medical and pharmacological researchclinical trials for others; Blood analysis services for scientific research purposes; Chemical engineering
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/04/2024
FIMP
FINAL DISPOSITION PROCESSED
11/04/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
GPNX
NOTIFICATION PROCESSED BY IB
02/27/2024
PUBO
PUBLISHED FOR OPPOSITION
02/20/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/07/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/31/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/16/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/14/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/14/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/14/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/14/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/14/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/14/2024
RFNT
REFUSAL PROCESSED BY IB
11/13/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/24/2023
RFRR
REFUSAL PROCESSED BY MPU
10/24/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/12/2023
CNRT
NON-FINAL ACTION WRITTEN
10/11/2023
DOCK
ASSIGNED TO EXAMINER
10/10/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/15/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/09/2023
Continuous trademark protection
Get notified about every new filing that threatens RECEPTKINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.